Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.40
Bid: 22.00
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.091%)
Open: 24.00
High: 24.40
Low: 24.00
Prev. Close: 23.00
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oncimmune Starts Trading On AIM As Motorpoint Shares Stay Firm (ALLIPO)

Wed, 18th May 2016 08:46

LONDON (Alliance News) - Oncimmune Holdings PLC shares slipped on their debut on London's AIM market on Wednesday, as unconditional dealings also started in Motorpoint Group PLC shares.

Oncimmune, an early cancer detection technology company, raised GBP11.0 million through the issue of shares at 130.00 pence per share. Its market capitalisation upon admission was around GBP66.3 million.

Shares in the company edged down in early dealings though, to 129.00p.

Oncimmune intends to use proceeds from the float to continue to develop its products, focused on auto-antibody tests which it said have the potential to detect cancer up to four years earlier than other methods, and can be applied to a "very wide range" of solid tumour types.

Meanwhile, unconditional dealings started on the London Main Market in shares of car dealer Motorpoint Group PLC. It floated last week, raising GBP100.0 million and starting life as a listed company with a GBP200.0 million market capitalisation.

Motorpoint shares were trading at 225.00p on Wednesday, 13% ahead of its 200.00p float price.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2020 09:10

Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses

Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses

Read more
28 Jan 2020 13:52

Oncimmune Reports Study Results For Cancer Test Product

Oncimmune Reports Study Results For Cancer Test Product

Read more
22 Nov 2019 16:05

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Nov 2019 13:33

Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test

Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test

Read more
31 Oct 2019 11:38

Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress

Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress

Read more
25 Sep 2019 11:32

CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility

CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility

Read more
23 Sep 2019 16:08

Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks

Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks

Read more
20 Sep 2019 15:47

Oncimmune funded into 2021 with new EUR 8.5m facility

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has secured a credit facility of €8.5m (£7.5m) with IPF Management, it announced on Friday.

Read more
20 Sep 2019 14:04

Oncimmune Secures EUR8.5 Billion Debt For Products Commercialisation

(Alliance News) - Oncimmune Holdings PLC on Friday said it has secured a credit facility of EUR8.5 million with IPF Management SA.The immunodiagnostics company said it will immediately draw

Read more
9 Sep 2019 12:07

Oncimmune "Thrilled" With EarlyCDT Lung Cancer Test Trial Result

(Alliance News) - Oncimmune Holdings PLC on Monday announced positive results from a trial of its EarlyCDT Lung test to detect early stage lung cancer.Shares in Oncimmune were up 5.5% at in

Read more
15 Jul 2019 12:55

Oncimmune Further Expands EarlyCDT Lung Sales In Spain Through Vithas

(Alliance News) - Oncimmune Holdings PLC on Monday said Sabartech SL, its existing distributor in Spain and Portugal, has agreed with Vithas Group to sell EarlyCDT Lung as a screening test for of

Read more
28 Jun 2019 11:03

Oncimmune sells US operations to and partners with Biodesix

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has entered into an exclusive partnership agreement, it announced on Friday, which it said could "unlock the full potential" of its 'EarlyCDT Lung' product in the United States.

Read more
26 Jun 2019 10:58

Oncimmune confident of 'material profitable revenues'

(Sharecast News) - Immunodiagnostics firm Oncimmune told investors on Wednesday it was confident it could generate "material profitable revenues" on the back of several business developments.

Read more
4 Jun 2019 09:56

Oncimmune Holdings Reports Positive Lung Cancer Study Results

LONDON (Alliance News) - Oncimmune Holdings PLC on Tuesday reported positive top line results from its early cancer detection test in patients with lung cancer.Oncimmune Holdings shares at

Read more
15 May 2019 15:27

Oncimmune distributor gets approval for 'EarlyCDT-Lung' in Israel

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Wednesday that its distributor for Israel, Best Medical Opinion, has received regulatory approval for the sale of the 'EarlyCDT-Lung' product in Israel.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.